HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

HAE

Haemonetics Corp.

Last Close
Oct 10 • 12:53PM ET
74.91
Dollar change
-1.20
Percentage change
-1.58 		%
Peers: ABT BAX BDX BSX EW HOLX MDT STE TFX XRAY
 | Held by: IJH VTI IWM VB VXF VBK IWO MDY SCHA SPMD
Scroll to Statements
IndexRUT P/E33.56 EPS (ttm)2.23 Insider Own1.10% Shs Outstand50.79M Perf Week-4.06%
Market Cap3.83B Forward P/E13.84 EPS next Y5.41 Insider Trans-6.38% Shs Float50.61M Perf Month3.40%
Income114.89M PEG2.10 EPS next Q1.07 Inst Own109.85% Short Float10.72% Perf Quarter-17.30%
Sales1.33B P/S2.87 EPS this Y16.11% Inst Trans10.72% Short Ratio9.42 Perf Half Y-13.42%
Book/sh17.70 P/B4.23 EPS next Y17.73% ROA5.10% Short Interest5.42M Perf Year-19.11%
Cash/sh6.73 P/C11.13 EPS next 5Y15.99% ROE12.98% 52W Range70.74 - 97.97 Perf YTD-12.40%
Dividend Est.1.00 (1.33%) P/FCF52.56 EPS past 5Y17.09% ROI5.41% 52W High-23.54% Beta0.31
Dividend TTM- Quick Ratio2.33 Sales past 5Y6.80% Gross Margin50.96% 52W Low5.89% ATR (14)1.95
Dividend Ex-Date- Current Ratio3.76 EPS Y/Y TTM-16.22% Oper. Margin14.65% RSI (14)41.63 Volatility1.97% 2.61%
Employees3657 Debt/Eq1.35 Sales Y/Y TTM9.47% Profit Margin8.61% Recom1.73 Target Price109.80
Option/ShortYes / Yes LT Debt/Eq1.35 EPS Q/Q-6.91% Payout0.00% Rel Volume0.55 Prev Close76.11
Sales Surprise0.33% EPS Surprise1.44% Sales Q/Q7.98% EarningsAug 08 BMO Avg Volume575.56K Price74.91
SMA20-2.57% SMA50-2.63% SMA200-9.01% Trades Volume172,263 Change-1.58%
Date Action Analyst Rating Change Price Target Change
Sep-13-24Initiated CL King Buy $116
Sep-11-24Initiated BofA Securities Neutral $85
Sep-10-24Initiated BTIG Research Buy $112
Jun-12-24Upgrade Needham Hold → Buy $112
Oct-13-22Initiated Mizuho Buy $90
Jan-27-22Downgrade Needham Buy → Hold
Dec-15-21Downgrade Citigroup Buy → Neutral $75 → $59
Aug-17-21Resumed Raymond James Outperform $75
Jun-17-21Initiated Citigroup Buy $75
May-14-21Upgrade CJS Securities Market Perform → Market Outperform
Show Previous Ratings
Oct-09-24 05:28PM
Haemonetics Corp (HAE) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges
(GuruFocus.com)
Oct-03-24 04:05PM
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
(PR Newswire)
Sep-24-24 08:00AM
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
(GlobeNewswire)
Sep-20-24 12:54AM
Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025
(Insider Monkey)
Sep-02-24 09:35AM
After Plunging -15.88% in 4 Weeks, Here's Why the Trend Might Reverse for Haemonetics (HAE)
(Zacks)
09:22AM Loading…
Aug-23-24 09:22AM
Implied Volatility Surging for Haemonetics (HAE) Stock Options
(Zacks)
Aug-16-24 09:08AM
Haemonetics (HAE) Set to Launch VASCADE MVP XL in US
(Zacks)
06:33AM
Haemonetics Vascade MVP XL vascular closure system enters US market
(Medical Device Network)
Aug-15-24 06:30AM
Haemonetics Announces Full Market Release for VASCADE MVP XL Vascular Closure System
(PR Newswire)
Aug-12-24 07:47AM
Haemonetics (HAE) Q1 Earnings Miss Estimates, Gross Margin Rises
(Zacks)
Aug-09-24 09:40AM
Is Haemonetics (HAE) Stock Undervalued Right Now?
(Zacks)
09:35AM
Down -14.6% in 4 Weeks, Here's Why Haemonetics (HAE) Looks Ripe for a Turnaround
(Zacks)
Aug-08-24 07:25AM
Haemonetics (HAE) Misses Q1 Earnings Estimates
(Zacks) -10.84%
06:25AM
Haemonetics: Fiscal Q1 Earnings Snapshot
(Associated Press Finance)
06:00AM
Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
(PR Newswire)
09:55AM Loading…
Aug-07-24 09:55AM
Wall Street Analysts See a 30.13% Upside in Haemonetics (HAE): Can the Stock Really Move This High?
(Zacks)
09:40AM
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term
(Zacks)
Aug-01-24 07:00AM
Sotera Health Appoints Christopher Simon to the Board of Directors
(GlobeNewswire)
Jul-30-24 06:00AM
Haemonetics Announces CE Mark Certification for the SavvyWire Pre-Shaped Pressure Guidewire
(PR Newswire)
Jul-29-24 10:20AM
Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
(Zacks)
Jul-16-24 09:45AM
Here's Why Haemonetics (HAE) is a Strong Growth Stock
(Zacks)
Jul-12-24 11:38AM
Haemonetics (HAE) Banks on Growing Hospital Arm, New Launches
(Zacks)
Jul-10-24 09:55AM
Wall Street Analysts Think Haemonetics (HAE) Could Surge 33.2%: Read This Before Placing a Bet
(Zacks)
Jul-08-24 04:05PM
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024
(PR Newswire)
Jun-27-24 09:35AM
Haemonetics (HAE) Loses -5.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
(Zacks)
Jun-19-24 01:26PM
Haemonetics (HAE) Expands VASCADE Line With New Limited Launch
(Zacks)
04:52AM
Haemonetics launches VASCADE MVP XL device for venous closure
(Medical Device Network)
Jun-18-24 04:15PM
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
(PR Newswire)
Jun-14-24 09:40AM
Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy?
(Zacks)
Jun-13-24 10:19AM
Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation
(Zacks)
09:45AM Loading…
Jun-03-24 09:45AM
Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term
(Zacks)
May-30-24 02:41AM
Insider Sale: President of Global Hospital at Haemonetics Corp (HAE) Sells Shares
(GuruFocus.com)
02:41AM
Insider Sale: EVP and General Counsel Michelle Basil Sells 12,990 Shares of Haemonetics Corp (HAE)
(GuruFocus.com)
May-29-24 09:40AM
Here's Why Haemonetics (HAE) is a Strong Value Stock
(Zacks)
May-27-24 12:45PM
3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE)
(Zacks)
May-24-24 09:55AM
Wall Street Analysts Believe Haemonetics (HAE) Could Rally 26.58%: Here's is How to Trade
(Zacks)
May-23-24 12:00PM
Haemonetics (HAE) Upgraded to Strong Buy: What Does It Mean for the Stock?
(Zacks)
06:00AM
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
(PR Newswire)
May-22-24 09:13AM
Here's Why You Should Buy Haemonetics (HAE) Stock Now
(Zacks)
02:06AM
Insider Sale: EVP Josep Llorens Sells Shares of Haemonetics Corp (HAE)
(GuruFocus.com)
May-21-24 04:05PM
Haemonetics Announces Proposed Convertible Senior Notes Offering
(PR Newswire)
May-17-24 12:00PM
Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid
(Zacks)
10:20AM
Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?
(Zacks)
May-14-24 09:15AM
Haemonetics Corporation (HAE) Hit a 52 Week High, Can the Run Continue?
(Zacks)
May-13-24 09:40AM
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term
(Zacks)
May-10-24 03:57PM
Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript
(Insider Monkey)
12:41PM
Haemonetics Corp (HAE) Fiscal 2024 Earnings: Aligns with EPS Projections, Reveals Robust ...
(GuruFocus.com)
10:53AM
Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand
(Zacks)
10:37AM
Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating
(MT Newswires)
May-09-24 10:55AM
HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024
(InvestorPlace)
09:30AM
Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say
(Zacks)
07:20AM
Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates
(Zacks)
06:39AM
Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise
(MT Newswires)
06:28AM
Haemonetics: Fiscal Q4 Earnings Snapshot
(Associated Press Finance)
06:00AM
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
(PR Newswire)
May-08-24 09:15PM
Insider Sale at Haemonetics Corp (HAE): EVP, Chief Technology Officer Anila Lingamneni Sells ...
(GuruFocus.com)
May-06-24 09:16AM
Exploring Analyst Estimates for Haemonetics (HAE) Q4 Earnings, Beyond Revenue and EPS
(Zacks)
May-01-24 11:51AM
Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs
(Zacks)
Apr-12-24 09:03AM
Why You Should Add Haemonetics (HAE) to Your Portfolio Now
(Zacks)
Apr-10-24 04:58PM
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
(PR Newswire)
Apr-08-24 03:20PM
Royce Investment Partners Commentary: What Will Fuel Small-Cap Returns?
(GuruFocus.com)
Apr-05-24 09:48AM
Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval
(Zacks)
Apr-04-24 06:30AM
Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge
(PR Newswire)
Apr-01-24 08:00AM
Haemonetics Corporation Completes Acquisition of Attune Medical
(PR Newswire)
Mar-29-24 09:30AM
Haemonetics (HAE) Crossed Above the 200-Day Moving Average: What That Means for Investors
(Zacks)
Mar-11-24 09:30AM
Haemonetics (HAE) Recently Broke Out Above the 50-Day Moving Average
(Zacks)
Mar-06-24 06:54AM
Haemonetics (HAE) Signs Agreement to Acquire Attune Medical
(Zacks)
Mar-05-24 06:18AM
Haemonetics to buy Attune Medical for $160M
(MedTech Dive)
06:00AM
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
(PR Newswire)
Feb-27-24 12:00PM
What Makes Haemonetics (HAE) a New Buy Stock
(Zacks)
Feb-21-24 05:57PM
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
(PR Newswire)
05:55PM
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
(PR Newswire)
Feb-18-24 01:26PM
25 Most Valuable Medical Device Companies in the US
(Insider Monkey)
Feb-09-24 10:39AM
Haemonetics (HAE) Q3 Earnings Top Estimates, 2024 View Raised
(Zacks) -5.01%
10:34AM
Haemonetics Corporation (NYSE:HAE) Q3 2024 Earnings Call Transcript
(Insider Monkey)
09:40AM
Here's Why Haemonetics (HAE) is a Strong Value Stock
(Zacks)
Feb-08-24 10:00PM
Q3 2024 Haemonetics Corp Earnings Call
(Thomson Reuters StreetEvents)
09:30AM
Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
(Zacks)
07:10AM
Haemonetics (HAE) Surpasses Q3 Earnings and Revenue Estimates
(Zacks)
06:33AM
Haemonetics Corp (HAE) Reports Revenue Growth and Updates Fiscal 2024 Guidance
(GuruFocus.com)
06:10AM
Haemonetics: Fiscal Q3 Earnings Snapshot
(Associated Press Finance)
06:00AM
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
(PR Newswire)
Feb-05-24 09:16AM
Haemonetics (HAE) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
(Zacks)
Feb-01-24 10:00AM
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?
(Zacks)
Jan-31-24 12:45PM
Is Haemonetics (HAE) a Solid Growth Stock? 3 Reasons to Think 'Yes'
(Zacks)
Jan-18-24 09:40AM
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term
(Zacks)
Jan-12-24 09:45AM
Here's Why Haemonetics (HAE) is a Strong Growth Stock
(Zacks)
Jan-11-24 04:05PM
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024
(PR Newswire)
Jan-03-24 01:56PM
Haemonetics (HAE) Up 11% in a Year: Will the Rally Continue?
(Zacks)
Dec-29-23 12:34PM
Here's Why Haemonetics (HAE) is a Strong Value Stock
(Zacks)
Dec-25-23 09:30AM
Haemonetics (HAE) Just Reclaimed the 200-Day Moving Average
(Zacks)
09:30AM
Haemonetics (HAE) Just Overtook the 50-Day Moving Average
(Zacks)
Dec-18-23 09:45AM
Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term
(Zacks)
Dec-15-23 12:45PM
Haemonetics (HAE) is an Incredible Growth Stock: 3 Reasons Why
(Zacks)
Dec-12-23 06:00AM
Haemonetics Corporation Completes Acquisition of OpSens Inc.
(PR Newswire)
Dec-07-23 04:05PM
Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
(PR Newswire)
Dec-05-23 09:40AM
Why Haemonetics (HAE) is a Top Value Stock for the Long-Term
(Zacks)
Dec-04-23 12:09PM
Here's Why You Should Invest in Haemonetics (HAE) Right Now
(Zacks)
Nov-30-23 09:35AM
Haemonetics (HAE) Loses -6.71% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
(Zacks)
Nov-28-23 12:45PM
3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE)
(Zacks)
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strong Stewart WPresident, Global HospitalJul 26 '24Sale91.154,312393,03918,196Jul 29 05:03 PM
Strong Stewart WOfficerJul 26 '24Proposed Sale91.154,312393,039Jul 26 09:47 AM
Lingamneni AnilaEVP, Chief Technology OfficerJul 11 '24Sale90.002,136192,24021,410Jul 15 04:27 PM
Lingamneni AnilaEVP, Chief Technology OfficerJul 12 '24Sale90.00797,11021,331Jul 15 04:27 PM
Simon, ChristopherPresident & CEOJun 06 '24Option Exercise41.64104,5164,352,046433,877Jun 07 04:15 PM
Basil Michelle LEVP and General CounselMay 29 '24Sale88.0812,9901,144,20831,257May 29 05:38 PM
Strong Stewart WPresident, Global HospitalMay 29 '24Sale87.538,857775,25318,196May 29 05:27 PM
Strong Stewart WPresident, Global HospitalMay 20 '24Option Exercise56.572,241126,77320,437May 21 06:01 PM
Strong Stewart WPresident, Global HospitalMay 20 '24Sale95.1168665,24518,196May 21 06:01 PM
Llorens JosepEVP, Global ManufacturingMay 20 '24Sale95.0898793,84421,310May 21 05:52 PM
Llorens JosepEVP, Global ManufacturingMay 17 '24Sale94.8282277,94216,350May 21 05:52 PM
Basil Michelle LEVP and General CounselMay 20 '24Sale95.081,604152,50831,257May 21 05:46 PM
Basil Michelle LEVP and General CounselMay 17 '24Sale95.001,073101,93529,352May 21 05:46 PM
Strong Stewart WPresident, Global HospitalMay 16 '24Option Exercise57.602,410138,81618,018May 17 05:11 PM
Strong Stewart WPresident, Global HospitalMay 16 '24Sale96.0473370,39715,608May 17 05:11 PM
Basil Michelle LEVP and General CounselMay 16 '24Sale96.1498594,69830,425May 17 05:02 PM
Llorens JosepEVP, Global ManufacturingMay 16 '24Sale96.1477074,02817,172May 17 04:55 PM
Lingamneni AnilaEVP, Chief Technology OfficerMay 06 '24Sale95.002,305218,97512,295May 08 04:21 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.